Family Medicine Doctors in Aberdeen, MD Accepting Medicare
6 Family Medicine doctors found. Showing 1 - 6
 Oliver Schoonmaker Thresher Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 995 Hospitality Way, Aberdeen, MD 21001 Phone: 410-306-7880 Fax: 410-306-7881 |
Dr. Bruce C Kinzinger, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 995 Hospitality Way, Aberdeen, MD 21001 Phone: 410-306-7880 Fax: 410-306-7881 |
 Dr. Gwenneth O Cancino, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 115 W Bel Air Avenue, Aberdeen, MD 21001 Phone: 410-272-3377 Fax: 410-273-1479 |
Ms. Tatyauna Lanier, FNP-C Family Medicine - Adult Medicine Medicare: Medicare Enrolled Practice Location: 650 Mchenry Rd, Aberdeen, MD 21001 Phone: 443-843-6262 |
Dr. Andrew Mrowiec, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9 Aberdeen Shopping Plz, Aberdeen, MD 21001 Phone: 410-272-8844 Fax: 410-272-8910 |
Dr. Derek Thomas Sueno-noel, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6455 Machine Dr, Aberdeen, MD 21005 Phone: 410-278-5475 Fax: 877-811-2184 |
News Archive
FDA panel votes against Amgen's Xgeva in prostate cancer
An FDA panel of oncologists has voted against a new use for Amgen's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients. Xgeva is already approved to prevent fractures in cancerous bones, and for osteoporosis, in a different formulation called Prolia.
Scientists discover genetic causes of Goldenhar syndrome
Some children are born with cleft palates and, of those children, some have an asymmetrical face and a malformed ear. A team of scientists led by Berlin-based researcher Enno Klußmann of the Max Delbrück Center for Molecular Medicine has taken an important step towards discovering the genetic causes of this condition, known as Goldenhar syndrome.
New findings from STELARA psoriasis clinical trial to be presented at 22nd World Congress of Dermatology
New findings to be presented from pooled analyses of the STELARA psoriasis clinical development program showed that the safety profile of STELARA and rates of adverse events remained consistent and stable over time in adults with moderate to severe plaque psoriasis receiving up to four years of treatment.
Pelosi releases statement on signing of Health Care and Education Reconciliation Act into law
Health insurance reform represents remarkable progress for the American people. Today, with President Obama's signature, health care becomes more affordable for the middle class, we begin closing the prescription drug donut hole, and we demand accountability from the insurance industry.
› Verified 6 days ago
Internal Medicine
Family Medicine
Psychiatry & Neurology
Anesthesiology
Pediatrics
Endocrinology, Diabetes & Metabolism